Dr. Cohn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Williams St
Suite 200
Denver, CO 80218Phone+1 303-388-4876Fax+1 303-285-5097
Education & Training
- University of Colorado School of MedicineFellowship, Hematology and Medical Oncology, 1991
- University of ColoradoResidency, Internal Medicine, 1985 - 1988
- University of ColoradoResidency, Internal Medicine, 1986 - 1987
- University of ColoradoInternship, Internal Medicine, 1985 - 1986
- University of Maryland School of MedicineClass of 1985
Certifications & Licensure
- CO State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- CORE Magazine Castle Connolly, 2006
Clinical Trials
- Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Start of enrollment: 2005 Sep 01
- A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Mar 01
- Study of Cabozantinib (XL184) in Adults With Advanced Malignancies Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1594 citationsPembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.Andrew X. Zhu, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara
The Lancet. Oncology. 2018-07-01 - 7 citationsModified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomize...Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino
Journal for Immunotherapy of Cancer. 2024-03-13 - 374 citationsClinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.Eric A. Klein, Donald A. Richards, Allen Lee Cohn, M.K. Tummala, Rosanna Lapham
Annals of Oncology. 2021-09-01
Press Mentions
- Photographer, Cancer Survivor Gives Presentation in Steamboat on Year Spent Shooting from His Car WindowSeptember 17th, 2019
- Increased Incidence Drives Novel Approaches Across Pancreatic Cancer SettingsJune 27th, 2019
- Rocky Mountain Cancer Centers First in Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine TumorsNovember 15th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: